McKesson Corporation  

(Public, NYSE:MCK)   Watch this stock  
Find more results for mck
162.60
+5.40 (3.44%)
Dec 15 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 157.56 - 164.29
52 week 133.82 - 169.29
Open 159.00
Vol / Avg. 3.32M/2.23M
Mkt cap 33.90B
P/E 7.70
Div/yield 0.34/0.84
EPS 21.11
Shares 208.00M
Beta 1.23
Inst. own 92%
Feb 7, 2018
Q3 2018 McKesson Corp Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Nov 7, 2017
McKesson Corp at Credit Suisse Healthcare Conference - Webcast
Oct 26, 2017
Q2 2018 McKesson Corp Earnings Release
Oct 26, 2017
Q2 2018 McKesson Corp Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '17) 2017
Net profit margin 0.11% 2.66%
Operating margin 0.46% 3.58%
EBITD margin - 2.13%
Return on average assets 0.36% 8.98%
Return on average equity 0.04% 51.89%
Employees 78,000 -
CDP Score - D

Address

1 Post St
SAN FRANCISCO, CA 94104-5203
United States - Map
+1-415-9838300 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare. It operates through two segments: McKesson Distribution Solutions and McKesson Technology Solutions. The distribution solutions segment distributes branded and generic pharmaceutical drugs and other healthcare-related products internationally and provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. Technology Solutions segment provides software and analytics, network solutions and technology-enabled services.

Officers and directors

John Harvey Hammergren Chairman of the Board, President, Chief Executive Officer
Age: 58
Bio & Compensation  - Reuters
James A. Beer Chief Financial Officer, Executive Vice President
Age: 56
Bio & Compensation  - Reuters
Kathleen D. McElligott Executive Vice President, Chief Technology Officer, Chief Information Officer
Age: 61
Bio & Compensation  - Reuters
Lori Ann Schechter Executive Vice President, Chief Compliance Officer, General Counsel
Age: 55
Bio & Compensation  - Reuters
Jorge L. Figueredo Executive Vice President - Human Resources
Age: 56
Bio & Compensation  - Reuters
Paul Coleman Julian Executive Vice President, Group President
Age: 61
Bio & Compensation  - Reuters
Bansi Nagji Executive Vice President - Corporate Strategy and Business Development
Age: 52
Bio & Compensation  - Reuters
Edward A. Mueller Lead Independent Director
Age: 70
Bio & Compensation  - Reuters
Andrew D. Bryant Independent Director
Age: 67
Bio & Compensation  - Reuters
N. Anthony Coles Jr., M.D. Independent Director
Age: 57
Bio & Compensation  - Reuters